Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
Go back to Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara| (NASDAQ: CODX) | Delayed: 1.12 +0.02 (1.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.10 | 52 Week High | $ | |||
| Open | $1.18 | 52 Week Low | $ | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.11 | EPS | $ | |||
| Volume | 280,420 | |||||
